The risk of specific cancers increases in patients with metabolic dysfunction, including obesity and diabetes. Here, we use Drosophila as a model to explore the effects of diet on tumor progression. Feeding Drosophila a diet high in carbohydrates was previously demonstrated to direct metabolic dysfunction, including hyperglycemia, hyperinsulinemia, and insulin resistance. We demonstrate that high dietary sugar also converts Ras/Src-transformed tissue from localized growths to aggressive tumors with emergent metastases. Whereas most tissues displayed insulin resistance, Ras/Src tumors retained insulin pathway sensitivity, increased the ability to import glucose, and resisted apoptosis. High dietary sugar increased canonical Wingless/ Wnt pathway activity, which upregulated insulin receptor gene expression to promote insulin sensitivity. The result is a feed-forward circuit that amplified diet-mediated malignant phenotypes within Ras/Src-transformed tumors. By targeting multiple steps in this circuit with rationally applied drug combinations, we demonstrate the potential of combinatorial drug intervention to treat dietenhanced malignant tumors.
INTRODUCTION
The prevalence of metabolism-related diseases, including type 2 diabetes and obesity, has been increasing worldwide. Metabolic disease impacts body homeostasis, leading to a constellation of symptoms, including cardiovascular disease, blindness, neuropathy, and nephropathy. Recently, the American Diabetes Association and American Cancer Society jointly published a consensus report emphasizing accumulating evidence that patients with diabetes also show elevated risks of specific cancer types (Giovannucci et al., 2010) . Epidemiological studies have provided strong evidence for the association between cancer and metabolic diseases, including diabetes and obesity (Barone et al., 2008; Calle et al., 2003; Coughlin et al., 2004; Inoue et al., 2006) ; patients with metabolic dysfunction have both a higher incidence of specific tumor types and a higher overall cancerrelated mortality. For example, obese patients with progesterone-receptor-negative breast cancer had a higher risk of lymph node metastasis, suggesting that metabolic dysfunction can promote tumor aggressiveness (Maehle et al., 2004) . The increase in metabolic diseases worldwide highlights metabolic dysfunction as an increasing issue in cancer progression. However, the mechanisms by which metabolic dysfunction contributes to cancer progression remain poorly understood.
Obesity and type 2 diabetes are typically associated with chronic hyperinsulinemia; levels of insulin in the blood rise to compensate for insulin resistance. Increased circulating insulin levels are in turn a risk factor for the development of hepatocellular carcinoma and colorectal cancer (Donadon et al., 2009; Kaaks et al., 2000) . Together with the well-documented mitogenic effects of insulin (Ish-Shalom et al., 1997) , this evidence suggests a role for hyperinsulinemia as a promoter of enhanced tumorigenesis in obese and diabetic patients. However, the development of insulin resistance in metabolism-related diseases raises a key question: how do tumors overcome insulin resistance to take advantage of increasing insulin levels? Here, we utilize Drosophila to explore the effects of high dietary sugar on tumor progression in vivo.
Feeding Drosophila a diet supplemented to 1.0 M sucrose led to insulin resistance, hyperglycemia, increased insulin levels (hyperinsulinemia), and accumulation of fat, phenocopying important aspects of type 2 diabetes (Musselman et al., 2011) . We used this model to explore the effects of high dietary sugar on tumor progression in vivo. On a normal diet, Csk/Src-dependent tumors were eliminated from the epithelium either alone or when paired with an oncogenic Ras isoform. In contrast, elevated dietary sugar strongly synergized with Ras/Src to generate large tumors associated with aggressive metastasislike behavior. Using this model system, we investigated whether increased insulin levels underlie induction of malignant tumors. Importantly, Ras/Src-activated tumors remained sensitive to insulin in dietary conditions that promoted insulin resistance in surrounding tissues. We demonstrate that increased insulin/PI3K signaling in turn prevents apoptosis and promotes canonical Wingless/Wnt mitogenic signaling in Ras/Src tumors. Our results provide functional data that, in the face of high dietary sugar, Ras/Src-activated cells escape insulin resistance to exhibit enhanced growth that is dependent on Wingless/Wnt mitogenic signaling.
RESULTS

High Dietary Sucrose Enhanced Tumor Growth
Feeding Drosophila a standard diet supplemented to 1.0 M sucrose (high dietary sucrose or ''HDS'') led to metabolic defects reminiscent of specific aspects of type 2 diabetes, including insulin resistance, hyperglycemia, elevated Drosophila insulinlike peptide (DILP) levels, and accumulation of body fat (Musselman et al., 2011) . To explore the link between metabolic dysfunction and tumor progression, we compared Drosophila cancer models fed HDS to those fed a control (0.15 M sucrose) diet. Combined elevation of Ras and Src pathway activities is a common motif in multiple cancer types, including breast, colorectal, and pancreatic cancer (Ishizawar and Parsons, 2004; Morton et al., 2010) . Experimentally, oncogenic K-Ras plus Src isoforms cooperate to accelerate the onset of pancreatic ductal adenocarcinoma in mice models, and Ras plus Src act together to promote tumorigenesis in Drosophila (Shields et al., 2011; Vidal et al., 2007) . We further developed this model by pairing transgenes that express oncogenic ras1 G12V in the eye with the genotypically null csk Q156Stop allele of Csk, a primary negative regulator of Src kinase. Clones were labeled with GFP to visualize tumor progression. In control eyes, GFP expression was comparable in control diet versus HDS, indicating that high-sucrose feeding did not alter transgene expression levels ( Figures 1A and 1B) .
Genotypically csk null clones alone were rarely obtained when fed either a control diet or HDS ( Figures 1C and 1D ) due to Srcmediated apoptosis (Vidal et al., 2006) . Also, as previously reported (Pagliarini and Xu, 2003) , targeting ras1 G12V to the eye resulted in isolated benign tumors that in turn led to lethality as pupae ( Figure 1E ). ras1 G12V animals fed HDS exhibited at most a mild increase in growth within the eye field ( Figure 1F ). Eyes with elevated Ras plus Src activity (ras1 G12V ;csk
) raised on a control diet displayed fewer and smaller GFP-positive clones compared to ras1 G12V -expressing clones alone (Figures 1E and 1G) , indicating that ras1 G12V expression cannot overcome elimination of csk mutant cells. By striking contrast, clones displayed strongly increased proliferation in 96.5% of ras1 G12V ;csk À/À larvae fed HDS. The result was striking overgrowth and a significantly enlarged GFP-positive eye field that dominated the head region (Figures 1H and 1I) . This overgrowth had consequences on animal viability; a majority (77.5%) of ras1 G12V ;csk À/À animals fed HDS failed to initiate pupariation, instead dying as larvae with multiple secondary tumors ( Figure S1A available online). Together, these results indicate that the metabolic status of the animals, as influenced by diet, strongly affects the outcome of Ras/Src-mediated tumorigenesis in the eye epithelium. HDS feeding led to an $4 day delay in completion of larval development (Musselman et al., 2011 ) ( Figure S1B) ; therefore, phenotypes were compared between developmental-stagematched animals fed HDS versus a control diet (late third-instar larvae). To rule out the possibility that enhanced tumor growth in HDS-fed animals was due to their older chronological age, we also analyzed progressive clone sizes in chronological-agematched animals ( Figures 1K-1S ). At day 9 after egg laying (AEL), larval eye tissue was significantly smaller in HDS-fed animals than in age-matched controls (12.9%; Figures 1M 0 , 1N 0 , and S1C), but the percentage area occupied by GFP-positive clones was already significantly larger (13.5% in control diet and 42.8% in HDS; Figures 1M 0 , 1N 0 , and 1S). This difference widened over time; control clones decreased from 35.2% (day 7 AEL) to 13.5% (day 9 AEL) of total area while HDS clones progressively increased, reaching 58.9% at day 11 AEL and 93.7% at day 13 AEL (Figures 1K-1S show enhanced tumor growth in a calorie-matched high-fat diet ( Figure S2C ), indicating that high levels of dietary carbohydrates, but not high total caloric levels, are responsible for the enhanced cancer phenotype. This is consistent with observations that a high-carbohydrate diet in general leads to metabolic defects in Drosophila not observed with caloriematched high-fat or high-protein diets (Musselman et al., 2011) .
HDS Promoted Aspects of Invasive Migration and Distant Secondary Tumors
Basement membrane degradation by matrix metalloproteases (MMPs) is a key early step in the initiation of cell spreading and metastasis (Deryugina and Quigley, 2006) . Eye epithelia from ras1
G12V
;csk À/À animals fed a control diet displayed an intact basement membrane as assessed by Laminin A (Figure 2A ). HDS feeding led to broad loss of Laminin A; loss was already evident at day 9 AEL (Figure 2B and S2D (J) Quantitation of the observed phenotypes. The blue bar represents eye discs without overgrowth (e.g., Figure 1G ), the red bar is eye discs with tumor overgrowth and overall enlarged tissue size (e.g., Figure 1H ), and the green bar is animals with secondary tumors (e.g., Figure 1I ). Results are shown as mean ± SEM. (K-R) Chronological-age-matched larvae fed a control diet or HDS. ras1 G12V ;csk À/À animals shown at day 7 AEL (K and L), day 9 AEL (M and N), day 11 AEL (O and P), and day 13 AEL (Q and R).
(K 0 , M 0 , N 0 , P 0 , and R 0 ) Matching dissected eye epithelial tissue stained with DAPI (red).
(S) Quantitation of the percentage of GFP-positive clone area percentage relative to total eye tissue area. Results are shown as mean ± SEM of individual eye discs. *Not assessed due to early (small discs, day 7) or late (everted pupal discs) stages. See also Figure S1 .
tumors ( Figures S2E, S2F , S2F 0 , and S2G), suggesting that levels of Src activity play a primary role in distant Ras/Src tumor formation. We also examined scribbled, which encodes a protein required to maintain apical/basal cell polarity (Bilder and Perrimon, 2000) . As previously reported (Pagliarini and Xu, 2003; Brumby and Richardson, 2003) , targeting ras1 G12V ;scrib À/À to the eye led to substantial overgrowth; however, we did not observe secondary tumors in these animals when fed either a control diet or HDS ( Figures S2H-S2J ). These results indicate a specific relationship between Ras and Csk/Src activities that, when combined with HDS, synergize to produce secondary tumors. The data also indicate that tumor overgrowth and secondary tumor formation are separable processes and, similar to mammals (Mehlen and Puisieux, 2006) , only a small subset of circulating cells successfully seed a secondary tumor. Larger secondary ras1 G12V ;csk À/À tumors were typically tightly associated with the tracheal system, a tubular network that transports oxygen ( Figures 2L-2O ). A Chitin-binding probe (Devine et al., 2005) indicated that secondary tumors enwrapped tracheal branches ( Figure 2Q ). Interestingly, Chitin was abnormally deposited within these tumor-imbedded trachea ( Figure 2Q ), suggesting either tracheal alteration or de novo branching. Consistent, but not proving the latter view, secondary ras1
;csk À/À tumors expressed Branchless ( Figure 2R ), a fly fibroblast growth factor (FGF) ortholog capable of promoting de novo trachea branching (Sutherland et al., 1996) . Together, these results indicate that HDS enhances or establishes multiple aspects of tumorigenesis in the presence of activated Ras/Src, including proliferation, a block in apoptosis, invasive migration, and establishment of secondary tumors distant from the primary tumor.
The PI3K Pathway Mediates Diet-Induced Tumorigenesis Genetically reducing PI3K activity through a hypomorphic allele of akt (ras1 G12V ;csk
,akt hypo/hypo ; Figure 3B ) or through feeding of the PI3K inhibitor wortmannin ( Figure S3 ) led to strongly reduced tumor cell survival in the presence of HDS. The Torclass inhibitor rapamycin displayed a similar reduction in tumor tissue ( Figure S3 ); in addition, animals were significantly smaller with an extended third-instar larval stage, as previously reported (Zhang et al., 2000 ;csk
;csk À/À animals fed a control diet led to overgrowth, but not secondary tumor formation.
(E) inR CA ,ras1
;csk À/À animals fed HDS.
(A 0 -E 0 ) Matching dissected eye epithelial tissue stained with DAPI (red).
(F) Quantitation of the observed phenotypes. The three color bars are explained in the legend of Figure 1J . Figure 3G ) (Musselman et al., 2011) . This led us to a central question in tumor metabolism studies: how does a diet that promotes insulin resistance also enhance tumors in an Insulin/PI3K-dependent manner? In contrast to controls, eye tissue within ras1
;csk À/À animals fed HDS exhibited an increase in baseline Akt when compared to control-diet-fed animals ( Figure 3H ), suggesting these tissues were in fact not insulin resistant. Consistent with this view, challenging eye tissue from HDS animals with exogenous Insulin led to a strong increase in phospho-Akt ( Figure 3H ). Insulin-stimulated increase in phospho-Akt was observed autonomously within the ras1
;csk À/À clones ( Figure 3I ). These data indicate that activating the Ras and Src pathways reversed HDSinduced insulin resistance, leading to hypersensitive responsiveness to Insulin. The result was increased sugar flux; in the presence or absence of exogenous Insulin, ras1
;csk À/À animals raised on HDS displayed a significant increase in glucose uptake to a level comparable to the triple combination inR CA , ras1
;csk À/À (Figures 3J-3N ). Reducing akt activity (ras1
) blocked glucose uptake ( Figure 3O ). We conclude that ras1
;csk À/À cells escape diet-induced insulin resistance to utilize both increased insulin responsiveness and insulinpathway-dependent glucose uptake. We next explored the mechanisms by which transformed cells evade insulin resistance.
Tumors Exhibit Aspects of an ''Undead'' Phenotype A central hallmark of mammalian cancer is the ability of transformed cells to evade apoptosis. In Drosophila developing eye and wing epithelia, keeping otherwise apoptotic cells alive (undead) by blocking effector caspase activity leads to aberrant tissue overgrowth due to compensatory proliferation of surrounding cells, a process designed to maintain tissue size and integrity (reviewed in Bergmann and Steller, 2010; Fan and Bergmann, 2008; Martín et al., 2009) . We used an antibody that recognizes the cleaved, active isoform of human caspase-3, a validated readout for activity of the Drosophila initiator caspase Dronc (Fan and Bergmann, 2010) . We observed broad Dronc activity in ras1
;csk À/À clones of animals raised on a control diet ( Figures 4A and S4A) . A significant proportion of these cells were undergoing apoptotic cell death as assessed by TUNEL staining (Figures 4D and S4A ).
In the presence of HDS, ras1
;csk À/À clones also exhibited broad cytosolic Dronc activity ( Figures 4B and S4A Figures 4J, S4D , and S4E). These results indicate that elevation of insulin pathway signaling through HDS leads to elevated Diap1 and a block in apoptotic cell death downstream of cleaved, activated Dronc. Interestingly, secondary tumors retained diap1 expression but lost Dronc activity ( Figures S4G and S4H) . we detected low levels of Wg protein within the clones in animals fed a control diet ( Figure 4K ). Notably, Wg protein levels were strongly upregulated in animals fed HDS ( Figures 4L and 4M ).
Reducing akt activity (ras1 G12V ;csk À/À ,akt hypo/hypo ) prevented this elevation ( Figure S4F ), whereas the triple combination inR CA ,ras1 G12V ;csk À/À displayed increased Wg levels in animals fed a control diet ( Figure 4N ). Activation of InR alone was not sufficient to elevate Wg levels ( Figure S5A ). We conclude that See also Figure S3 . combining elevated InR, Ras, and Src activities leads to elevated Wg expression in discrete tumors.
Elevation of Wg contributed to tumor progression. Reducing Wg activity (ras1 G12V ;csk
,wg RNAi ) in animals fed HDS led to strong suppression of tumor growth ( Figure 5B ). Expression of a dominant-negative isoform of the downstream pathway effector Tcf (ras1
;csk À/À ,tcf DN ) also suppressed tumor growth ( Figure 5C ), indicating that canonical Wg signaling is required for high-sucrose-induced enhancement of tumorigenesis. As a result, whereas only 22.5% of ras1 G12V ;csk À/À animals successfully initiated pupariation when fed HDS, 100% of ras1 G12V ;csk
,tcf DN animals successfully pupariated when fed HDS ( Figures S5B and S5C) .
In undead cells, Jnk pathway signaling is required for ectopic Wg expression (Ryoo et al., 2004 Figure 5F ). Together, these results indicate that ras1 G12V ;csk À/À cells achieve an undead status through Diap1, which then activates a InR-Jnk-Wg pathway that promotes cell-autonomous proliferation. We next asked whether this ability of Wg to mediate key aspects of HDS/insulin pathway activity within Ras/Src-activated tumors extended to evasion of insulin resistance.
Canonical Wingless/Wnt Pathway Signaling Promotes Insulin Sensitivity by Regulating InR Expression
In organ culture experiments from animals fed HDS, challenging control tissue with exogenous Insulin led to little or no increase in pathway activity as assessed by phosphorylated Akt ( Figure 5G) ; we also observed significant downregulation of inR messenger RNA (mRNA) ( Figure 5H ), which presumably at least partially accounts for the tissues' insulin resistance. Two other members of the Insulin pathway, Chico/IRS and Lnk/SH2B, showed no change in transcript levels ( Figure 5H ), suggesting that diet-directed downregulation is specific to InR. In contrast, tissue expressing Wg responded to exogenous Insulin by strongly activating pathway signaling ( Figure 5G ). This suggests that, in addition to Insulin regulating Wg, Wg regulates Insulin signaling, potentially through the regulation of inR expression. Consistent with this model, inR mRNA levels were significantly upregulated in ras1 G12V ;csk À/À eye clones in animals fed HDS ( Figure 5I ). The result was an increase in phosphorylated, activated InR that was strongly enhanced when the tissue was challenged with exogenous Insulin ( Figure 5J) . Importantly, the diet-dependent increase in inR mRNA levels was suppressed by reducing activity of the Wg target Tcf (ras1
G12V
;csk À/À ,tcf DN ; Figure 5I ). These results indicate that canonical Wg signaling promotes insulin sensitivity by upregulating inR transcripts. That is, transformed tissue evaded insulin resistance through a feed-forward mechanism by which elevated Wg directs elevated InR ( Figure 5K ). ;csk À/À animals was determined at day 17 AEL. Results are shown as mean ± SEM. See also Figure S6 .
Combinatorial Multinode Drug
Treatments for Diet-Induced Ras/Src Tumorigenesis Identifying an HDS-dependent undead cell phenotype in ras1 G12V ;csk À/À tissue suggested specific points of therapeutic intervention: (1) conversion of dietary sucrose, (2) InR/PI3K metabolic signaling, (3) canonical Wg/Wnt pathway undead cell signaling, and (4) Ras plus Src oncogenic pathways ( Figure 5K ). Nearly threequarters of ras1 G12V ;csk À/À animals raised on HDS failed to pupariate due to aggressive eye tumors; we utilized pupariation rate as a quantitative viability assay to take a stepwise approach toward identifying an optimized whole-animal therapeutic cocktail. Time to pupariation was not affected by drug treatments when compared to vehicle (DMSO) treatment alone; pupariation rates were assessed at day 17 AEL, after pupariation curves reached a plateau ( Figure S6A) .
Acarbose is an inhibitor of a-glucosidase that is used to treat type 2 diabetes mellitus (Anderson, 2005) . Feeding acarbose in the presence of HDS led to reduced tumor growth and improved ras1 G12V ;csk À/À animal survival ( Figures 6B and 6J ). Pyrvinium, a small-molecule inhibitor of the canonical Wnt-signaling pathway (Thorne et al., 2010) , suppressed HDS-induced tumor growth at a concentration that did not affect the growth of wild-type clones ( Figures 6C and S6B) ; 41.9% of HDS-and pyrvinium-fed animals achieved pupariation ( Figure 6J ). We recently developed polypharmacological anticancer compounds (Dar et al., 2012 ) that target the Ras, Src, and Tor pathways as single agents. These represent the central cellular pathways that mediate HDSinduced tumor growth in ras1 G12V ;csk À/À animals and, indeed, the compound AD81 suppressed Ras/Src-tumorigenesis and larval lethality of animals fed HDS ( Figures 6D and 6J) . Biochemical analysis of dissected eye tissues supported inhibition of Ras, Src, and Tor pathways by AD81 feeding, though not by the close analog AD80 ( Figure 6I ) (Dar et al., 2012) . Furthermore, AD81 also suppressed tumor growth and larval lethality of in-R CA ,ras1 G12V ;csk À/À animals fed a control diet, demonstrating AD81 can act tumor autonomously ( Figure S6C) . Targeting sugar or the Ras, Src, PI3K, or Wg pathways showed significant but limited efficacy on ras1 G12V ;csk À/À tumors in animals fed HDS. Combining acarbose with pyrvinium, acarbose with AD81, or pyrvinium with AD81 enhanced survival to permit 64.4%, 62.9%, and 68.5%, survival of ras1 G12V ;csk
animals to pupariation in the presence of HDS, respectively (Figures 6E-6G and 6J) . Strikingly, the triple combination acarbosepyrvinium-AD81 achieved a 91.2% rescue level of ras1 G12V ;csk À/À animals fed HDS ( Figures 6H and 6J ), far higher than any single or double drug combination we have tested. We conclude that targeting multiple nodes in a rational manner may be required to achieve an optimal therapeutic index, balancing efficacy with minimal whole-animal toxicity.
DISCUSSION
Epidemiological studies provide strong evidence for an association between metabolism-related diseases and cancer, but the underlying mechanisms that link these two diseases remain poorly understood. In this study, we demonstrate that dietary sucrose strongly enhances multiple aspects of Ras/Src-activated tumors in Drosophila. HDS led to stabilization of tumors within the epithelium, increased proliferation, and metastasis-like behavior. Mechanistically, we provide evidence that Ras/Srcactivated cells increase insulin pathway sensitivity in an otherwise insulin-resistant environment, allowing them to take advantage of high circulating glucose. The result is a Wg-and Jnk-dependent enhancement of tumor progression. Our results support a model in which Ras/Src cells become hypersensitive to circulating Insulin, leading to efficient activation of insulin/ PI3K signaling ( Figure 5K) . A key consequence of increased insulin/PI3K signaling was the prevention of apoptosis and the promotion of elevated levels of Wg expression and activity; these two aspects promoted an undead-like cell phenotype that further enhanced proliferation. We observed low but detectable levels of Wg expression in ras1 G12V ;csk À/À clones in animals fed a control diet ( Figure 4K ); these clones exhibited high levels of apoptosis. In contrast, Wg accumulated at significantly higher levels in ras1 G12V ;csk À/À tumors within animals fed HDS ( Figure 4L ).
High Wg levels led to elevated Diap1 expression and reduced apoptosis, stabilizing ras1 G12V ;csk À/À clones and revealing accumulation of Wg within the clone. Our model suggests that inhibition of cell death in ''HDS tumors'' is a key aspect of Ras/ Src-mediated transformation and may allow cells to stably and continuously produce Wg. Wg was expressed within ras1 G12V ;csk À/À cells in the presence of HDS ( Figure 4L and 4M), and phosphorylated Akt levels increased within Ras/Src clones, but not detectably in nearby wild-type cells ( Figure 3I ). Therefore, unlike the conventional undead situation (induced by Hid plus P35), a Wg-mediated increase in InR expression and signaling provides a growth advantage specifically within Ras/Src cells rather than surrounding wild-type tissue. Together, our data provide evidence that the undead cell phenotype generates an InR-Jnk-Wg-InR feed-forward mechanism that results in elevated InR expression and a reversal of insulin resistance ( Figure 5K ). The result is transformed tissue that is optimized for insulin-dependent glucose uptake in an animal with hyperinsulinemia and hyperglycemia. The undead phenotype was not fully maintained in secondary tumors; Dronc expression was lost in distant tumors of ras1
G12V
;csk À/À , though diap1 expression was maintained (Figures S4G and S4H) . These results suggest that secondary tumors develop progressively distinct properties; understanding these changes will require additional studies. A Chitinbinding probe suggested progressive steps of tubule maturation within secondary tumor-associated trachea, including potentially newly expressed Chitin scattered within immature tubules, tubules filled with solid projections of Chitin, and hollowed out mature tubules ( Figure 2Q ). Additional studies will be required to confirm that this represents neotracheogenesis and, if so, whether this occurs through processes reminiscent of the neoangiogenesis that is a common feature of mammalian metastasis (Bergers and Benjamin, 2003) . Strikingly, secondary tumors expressed high levels of the FGF ortholog Branchless, an important step in promoting tracheogenesis during development ( Figure 2R ; Sutherland et al., 1996) . The Drosophila Wnt ortholog Wg promotes a tumor's ability to evade insulin resistance through its regulation of inR expression in the presence of HDS feeding, which otherwise promotes diabetes-like phenotypes ( Figure 5H ) (Musselman et al., 2011) . High Wg expression requires both Ras/Src activation and HDS, promoting inR expression through canonical Wg-dTcf signaling (Figure 5I) . These results emphasize a link between canonical Wg signaling and Insulin signaling. Consistent with this model linking canonical Wg and Insulin signaling pathways, a recent study reports that reduced expression of skeletal muscle Insulin receptor, which is linked to hyperinsulinemia and insulin resistance, is enhanced by a mutation in the Wnt coreceptor LRP6 in humans (Singh et al., 2013) .
Tumors with Wnt activation may represent tumor types that respond and synergize with metabolic defects. Wnt activation is frequently observed in many tumor types, including those with a strong association with diabetes, such as hepatocellular carcinomas and colorectal cancers; activating mutations in b-catenin and loss-of-function mutations in APC are frequently found in human hepatocellular carcinoma and colorectal cancers (Fodde et al., 2001; Laurent-Puig and Zucman-Rossi, 2006) . Incidence of pancreatic cancer has a particularly strong association with diabetes, suggesting that its constituent mutation load may interface with metabolic dysfunction. Activating mutations in K-Ras plus upregulation of Src activity are commonly found in pancreatic ductal adenocarcinoma (PDA) (Almoguera et al., 1988; Morton et al., 2010) , and a mouse KRas/Src pancreatic model developed PDA with shortened latency (Shields et al., 2011) . Wnt ligands and transcriptional target genes of b-catenin are highly expressed in PDA (Pasca di Magliano et al., 2007) , a phenomenon reminiscent of our observations linking diet, Ras/Src, and Wnt signaling. A clear link has yet to be established between pancreatic cancers featuring elevated Ras/Src activity and/or Wnt-pathway activation within diabetic patients.
Our data indicate that limiting dietary sucrose directly or through blocking its intermediates through compounds such as acarbose may reduce important aspects of tumor risk and progression in individuals with metabolism-related diseases. Combining acarbose with drugs that target the triggering Ras/ Src pathways plus components of the amplification circuit provided the most robust therapeutic impact on diet-enhanced tumors in our model. These results provide a potential explanation for how insulin-resistant animals are at increased risk for tumorigenesis and emphasize the importance of targeting multiple, specific nodes to achieve optimal therapeutic value. 
Cultures
Cultures were carried out on Bloomington semidefined medium (described by the Bloomington Stock Center) with modifications. Detailed recipes for the control diet, HDS, and the high-fat diet have been previously described (Musselman et al., 2011) . The following final concentrations of carbohydrates included 0.15 M sucrose (control diet), 1.0 M sucrose (HDS), and 2.0 M glucose (high-glucose diet). Cultures were performed at 25 C unless otherwise noted.
Immunofluorescence and TUNEL Labeling
Larval eyes were dissected in PBS, fixed in 4% paraformaldehyde (PFA) in PBS or PLP-fixative (2.5% PFA, 0.075 M lysine, 0.25% [w/v] Na-periodate in phosphate buffer), washed in PBT (PBS containing 0.1% Triton X-100), and incubated with primary antibodies in PAXDG (PBS containing 1% BSA, 0.3% Triton X-100, 0.3% deoxycholate, and 5% goat serum), followed by washing and incubation with secondary antibodies in PAXDG. Tissues were counterstained with TO-PRO-3 (Invitrogen) and mounted in Vectashield mounting media (Vector Laboratories). Antibodies used were rabbit anti-cleaved caspase-3 (Asp175; Cell Signaling), mouse anti-dMMP1 (Developmental Studies Hybridoma Bank [DSHB]), mouse anti-Wingless (DSHB), mouse anti-b-galactosidase (DSHB), rabbit anti-Laminin b 1 (Abcam), rabbit anti-phospho-histone H3 (Ser10; Millipore), rabbit anti-Diap1 (a gift from H. Steller), rabbit anti-phospho-Akt (Ser473; Cell Signaling), and rat anti-Branchless (a gift from M. Krasnow). Secondary Alexa-568-conjugated anti-mouse and anti-rabbit antibodies were used (Molecular Probes). To label tracheal lumen, Rhodamine-conjugated Chitin-binding probe was used (New England Biolabs). TUNEL was performed using the TMR-Red In Situ Cell Detection Kit (Roche Diagnostics). Samples were fixed for 15 min in 4% PFA in PBT, washed in PBT and permeabilized in 100 mM sodium citrate/0.1% Triton X-100 at 65 C for 30 min, washed in PBT, and free DNA ends were fluorescein labeled.
Fluorescent and confocal images were taken with Leica DM5500 microscope equipped with DFC340 FX Monochrome Digital Camera and TSC SPE confocal microscope.
Drugs
Compounds solubilized in DMSO were diluted directly into the fly medium and vortexed extensively to obtain homogeneous culture. Drugs used were wortmannin and rapamycin (LC Laboratories) and acarbose and pyrvinium pamoate (Sigma). AD compounds were provided by A. Dar and K. Shokat (UCSF).
Western Blotting
Wandering third-instar larvae were rinsed in PBS; the eye discs were dissected out and placed in Schneider's Drosophila medium on ice. The eye discs were incubated with or without 5 mM recombinant human Insulin (Sigma) for 15 min at room temperature. Eye discs were transferred to a microcentrifuge tube and spun down briefly. The supernatant was discarded and the remaining precipitates were suspended in SDS sample buffer at a concentration of 10 ml/mg tissue and used to generate western blots. Antibodies used targeted total Akt (Cell Signaling), phospho-Drosophila Akt (Ser505; Cell Signaling), phospho-IGF-1 receptor b (Tyr1131)/Insulin receptor b (Tyr1146; Cell Signaling), and Syntaxin (DSHB). Secondary antibodies were from Cell Signaling.
Glucose Uptake Assay
For the glucose uptake experiments, flies with the genotype ey(3.5) FLP1; act > y+ > gal4; FRT82B, tub-gal80 were crossed with flies with the following genotypes: (1) Wandering third-instar larvae were rinsed in PBS; the eye discs were dissected out and placed in Drosophila larval saline (HEPES-NaOH [pH 7.1], 87 mM NaCl, 40 mM KCl, 8 mM CaCl 2 , 8 mM MgCl 2 , 50 mM sucrose, and 5 mM trehalose) on ice. The eye discs were incubated with or without 5 mM recombinant human Insulin (Sigma) in the presence of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NBDG: Invitrogen) for 15 min at room temperature. The tissues were washed with Drosophila larval saline and mounted with a Vectashield (Vector Laboratories).
Quantitative RT-PCR Total RNA was extracted from the eye discs using the QIAGEN RNeasy Mini Kit. Oligo-dT primers and Superscript RT-II reverse transcriptase (Invitrogen) was used to synthesize first-strand DNA. PCR was performed using Power SYBR Green PCR Master Mix (Applied Biosystems) and analyzed on the Applied Biosystems StepOnePlus real-time PCR system. Results were normalized to Kinesin mRNA, and RpL32 was used as a control. The following primers were used: Kinesin-f, 5 0 -GCTGGACTTCGGTCGTAGAG-3 0 ; Kinesin-r, 
